Ergebnis der Suchanfrage nach N&amp

BAUER Aktiengesellschaft

EANS-News: BAUER Aktiengesellschaft / BAUER AG improves total Group revenues and earnings in the first quarter

• Total Group revenues up 17.8 percent to EUR 307.5 million • After-tax loss of EUR 2.6 million better than previous year comparative (EUR 4.4 million loss) • Orders received up 24.1 percent to EUR 363.9 million (previous year: EUR 293.2 million) • Orders in hand in Resources segment boosted to high level of ...

Lonrho Plc

Lonrho's Oceanfresh Wins Pick n Pay Private Label Account

London (ots/PRNewswire) - Lonrho's Oceanfresh has announced that after a lengthy product testing and development program Oceanfresh has been chosen to supply 16 of the 19 items that Pick n Pay will be launching under their private label brand. The new range includes product lines for general day to day consumption as well as new products that will form part of the prestigious 'Finest Range' category from Pick n Pay. First ...

BAUER Aktiengesellschaft

EANS-News: BAUER Aktiengesellschaft / BAUER AG ends year fully to plan and looking to return to growth in 2011

• Total Group revenues up 2.2 percent to EUR 1,304 million • Profit after tax of EUR 39.8 million (previous year: EUR 42.0 million) to plan • Orders received up 26.7 percent to EUR 1,410.0 million (previous year: EUR 1,113.1 million) • Forecast for 2011: Total Group revenues up to EUR 1.4 billion and profit ...

Polytec Holding AG

EANS-Adhoc: Polytec Holding AG / POLYTEC GROUP - Group results 2010 confirm the turnaround

Contact: Manuel TAVERNE POLYTEC GROUP Investor Relations Tel.+43(0)7221/701-292 manuel.taverne@polytec-group.com Branche: Industrial Components ISIN: AT0000A00XX9 WKN: A0CA1R Index: ATX Prime Börsen: Wien / official market ...

USU Software AG

EANS-News: USU Valuemation 4.1 for Knowledge-Based Service Management Now Available

Contact: Gerick Thomas Branche: Software ISIN: DE000A0BVU28 WKN: A0BVU2 Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Düsseldorf / free trade Hannover / free trade München / free trade Stuttgart / regulated dealing ...

Astellas Pharma Europe Limited

Phase III Results Show Mirabegron Improves Key OAB Symptoms

Tokyo (ots/PRNewswire) - Astellas Pharma Inc. (http://www.astellas.com/en/corporate/) today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition.(1,2) These data were presented for the ...

Bristol-Myers Squibb GmbH & Co. KGaA

BARACLUDE(R) (entecavir) Approved by the European Commission for the Treatment of Chronic Hepatitis B in Adult Patients With Evidence of Decompensated Liver Disease

Paris (ots/PRNewswire) - Bristol-Myers Squibb announced today that BARACLUDE(R) (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients with evidence of decompensated liver disease. BARACLUDE(r) was already approved in Europe in June 2006 ...

Opawica Exploration Inc.

EANS-News: Opawica announces gold & copper drill results from Atikwa Lake, Ont.

Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Research & Development Vancouver, BC VJ 2M9 (euro adhoc) - Opawica Explorations Inc. (TSX.V: OPW) ("Opawica"/ the "Company") announces the following drill hole results from the Company's 100% owned Atikwa Lake gold and copper project, ...

Orange

Orange Accelerates the Deployment of Mobile Contactless Services With Launch of the Samsung Wave 578 in Europe

Barcelona, Spain (ots/PRNewswire) - As the first European operator to announce that we would deploy a new generation of SIM cards and handsets to facilitate mobile contactless services, Orange has extended its successful and long-term relationship with Samsung to deliver handsets enabled for NFC (Near ...

Softline AG

EANS-News: Softline continues its international expansion course in Belgium

Softline establishes its Belgian subsidiary Softline Solutions N.V. - in Zaventem near Brussels Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Global Expansion/Plant Openings Subtitle: Softline establishes its Belgian subsidiary Softline Solutions N.V. - in Zaventem near ...

Agence de Medecine Preventive (AMP)

AMP's SIVAC Initiative Supports Mozambique to Set Up its National Immunization Technical Advisory Group (NITAG)

Paris (ots/PRNewswire) - The inaugural meeting of Mozambique's Committee of Experts on Immunization (Comité de Peritos para a Imunização, CoPI) was held in Maputo on January 7, 2011. The CoPI is the second National Immunization Technical Advisory Group (NITAG) in a sub-Saharan African country eligible for ...

Opawica Exploration Inc.

EANS-News: Opawica announces Au-Cu drilling results from Atikwa Lake, Ontario, confirms mineralized Footwall Zone of up to 183 meters in width

Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Research & Development Vancouver, Canada (euro adhoc) - Opawica Explorations Inc. (TSX.V: OPW / OTC: OPWEF / Frankfurt: 0E5A) ("Opawica"/ the "Company") announces the following drill ...

Agence de Medecine Preventive (AMP)

AMP's SIVAC Initiative Supports the Creation of a Mongolian National Immunization Technical Advisory Group (NITAG)

Paris (ots/PRNewswire) - The inaugural meeting of the Mongolian National Immunization Technical Advisory Group (NITAG) was held at the Ministry of Health in Ulaanbaatar on December 6, 2010. The NITAG is the first of its kind in Mongolia and was established based on recommendations from the World ...

Bristol-Myers Squibb GmbH & Co. KGaA

European Approval for SPRYCEL(R) (dasatinib) in Adult Patients With Newly Diagnosed CML: First New Approved Treatment in the E.U. With Superior Efficacy vs. Imatinib Since 2001

Paris (ots/PRNewswire) - Bristol-Myers Squibb today announced that SPRYCEL(R) (dasatinib) 100mg once daily received Marketing Authorization from the European Commission for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) Chronic Myelogenous Leukaemia in Chronic Phase ...

Geobrugg AG

Geobrugg AG: Prestigious "Safety Initiative of the Year" award goes to Switzerland

Eli Lilly and Company

Mortality Data Presented for Patients Treated with Efient(R)/Effient(R) (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery

Chicago, November 16 (ots/PRNewswire) - New results from an observational substudy from TRITON-TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Efient(R)/Effient(R) (prasugrel) prior to coronary artery bypass graft surgery (CABG) ...

BAUER Aktiengesellschaft

EANS-News: BAUER Aktiengesellschaft / BAUER AG progressing as planned after nine months: forecast reaffirmed and concretized

• Total Group revenues up 1.9 percent from EUR 944.5 million to EUR 962.6 million • Sales revenues up 8.0 percent to EUR 844.4 million (previous year: EUR 782.2 million) • Profit after tax EUR 21.0 million (previous year: EUR 30.0 million) • Orders received up 27.7 percent to EUR 1,042.1 million (previous ...

Opawica Exploration Inc.

EANS-News: Opawica Exploration Inc. /

Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information VANCOUVER, Canada (euro adhoc) - Opawica Explorations Inc. (TSX.V: OPW / OTC: OPWEF / Frankfurt: OE5A) ("Opawica" / the "Company") announces the following drill hole results from the Company's Atikwa Lake gold and copper project near Kenora, Ontario. Results ...

Bristol-Myers Squibb GmbH & Co. KGaA

SPRYCEL(R) (dasatinib) Receives CHMP Positive Opinion for the Treatment of Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukaemia in Chronic Phase

Paris (ots/PRNewswire) - Bristol-Myers Squibb today announced that SPRYCEL(r) (dasatinib) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive Chronic Myelogenous Leukaemia in Chronic ...

The International Menopause Society (IMS)

International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women

London (ots/PRNewswire) - To mark World Menopause Day on 18th October 2010, the International Menopause Society (IMS) is launching new Recommendations for the management of postmenopausal vaginal atrophy, a distressing condition that will affect up to half of women after menopause.[1] This new guidance is ...

ETAM

Natalia Vodianova and Etam: An International Love Story

Paris (ots/PRNewswire) - The Etam muse, designer of two lingerie collections a year and Russian top model, Natalia Vodianova, is continuing her collaboration with the French brand. Seduction, joy, generosity, fashion and pleasure are the true common values that unite Etam and Natalia Vodianova. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/etam/44220/ With a ...

AstraZeneca GmbH

Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients

London and San Francisco (ots/PRNewswire) - AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc. , significantly improved outcomes of patients with rheumatoid arthritis (RA) who responded inadequately to ongoing treatment with methotrexate (MTX), ...

sanofi-aventis Group

Sanofi-aventis: Adding Lantus(R) to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients With Type 2 Diabetes

Paris (ots/PRNewswire) - Sanofi-aventis announced today results of two studies presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden. The first pooled analysis using patient-level data from randomized clinical trials demonstrated that adding ...

sanofi-aventis Group

Sanofi-aventis: Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients With Type 2 Diabetes

Paris (ots/PRNewswire) - Sanofi-aventis announced today the first Phase III results of the GetGoal clinical trial program assessing the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, as monotherapy in patients with type 2 diabetes. These results were presented at the ...